National THCA banNew federal hemp THC limits take effect Dec. 11, 2026Starts Dec. 11: see what changes

Dec. 11, 2026Shop THCA
Educational cannabis news and practical guides for adults 21+. Not medical, legal or investment advice. Affiliate links are disclosed where used.

Independent cannabis reporting and practical guides for adults.

News, research, medical access, business, culture, reviews, and local guides.

CannaWize Co
Latest

Terpenes · Terpene Profile · 6 min read

Beta-Caryophyllene: The Peppery Terpene That Acts Like a Cannabinoid

Of all the cannabis terpenes, beta-caryophyllene has the most consistent lab evidence for acting on the endocannabinoid system. It’s also in your pepper grinder.

All Terpene GuidesBrowse Cannabinoids →

Beta-caryophyllene (often shortened to BCP) gives black pepper and cloves their spicy, woody bite, and it is a major terpene in many cannabis varieties. In 2008, researchers reported in PNAS that it binds to and activates the CB2 cannabinoid receptor, earning it the label “dietary cannabinoid.” That finding is solid, but it is often stretched into treatment claims that the research does not support.

CannaWize title card: Beta-caryophyllene, a peppery terpene also found in black pepper, cloves and hops
CannaWize illustration.
The short version

Beta-caryophyllene selectively binds the CB2 receptor and activates it. CB2 is mostly involved in immune signaling; it is not the CB1 receptor responsible for THC’s high. In mice, oral beta-caryophyllene reduced inflammation and some kinds of pain, and those effects disappeared in mice lacking CB2. We found no controlled human trials testing it as part of cannabis.

What the 2008 Discovery Showed

A team led by Jürg Gertsch at ETH Zurich reported that (E)-beta-caryophyllene binds selectively to the CB2 receptor and acts as a functional agonist, meaning it switches the receptor on. In human immune cells it reduced inflammatory signaling. In mice, an oral dose of 5 mg per kg reduced inflammation in a standard test, but not in mice bred without CB2 receptors. That last detail is what makes the finding convincing: the effect depended on the receptor. The authors described it as a “nonpsychoactive” CB2 ligand found in foods and in cannabis.

Pain Studies in Mice

A 2014 follow-up in European Neuropsychopharmacology found that oral beta-caryophyllene reduced inflammatory pain responses in mice in a CB2-dependent way, while it had no effect on acute pain. In a nerve-pain model, longer-term treatment reduced pain sensitivity and spinal inflammation, and the mice did not develop tolerance. These are promising animal results. They have not been confirmed in controlled human trials of cannabis or beta-caryophyllene for pain.

How It Fits the Entourage Debate

Beta-caryophyllene is the terpene that holds up best in receptor studies. A 2020 study that found no cannabinoid-receptor activity for other common terpenes still noted a possible weak interaction of beta-caryophyllene with CB2. A 2019 study using a different method found no CB2 activation from it. So even here the lab picture is not unanimous, and receptor activity in cells does not show that the amount in cannabis changes how a person feels. See our entourage effect review.

CB1 vs. CB2: Why It Won’t Get You High

ReceptorWhere it’s mostly foundBeta-caryophyllene?
CB1Brain and nervous system; drives THC’s intoxicating effectsNot a target; the 2008 study found it binds selectively to CB2
CB2Immune cells and peripheral tissues; involved in inflammationBinds and activates it selectively

Because it targets CB2 rather than CB1, beta-caryophyllene is not intoxicating. It is used as a flavoring in food, and you eat it whenever you use black pepper.

What This Means for You

  • Beta-caryophyllene is one of the more scientifically interesting terpenes, and a peppery, spicy profile is a fair thing to look for on a lab report.
  • Be skeptical of products that promise pain or inflammation relief because they contain it. The supporting studies are in mice.
  • If you are managing pain, talk with a clinician. Our chronic pain research review covers what human cannabis studies show.

Clear answers

Frequently Asked Questions

Is Beta-Caryophyllene a Cannabinoid?

Chemically it is a terpene, but it acts like a cannabinoid at one receptor. A 2008 PNAS study showed it binds and activates CB2, and the authors called it a dietary cannabinoid.

Does Beta-Caryophyllene Get You High?

No. It acts on CB2 rather than CB1, the receptor responsible for THC’s high, and the 2008 study described it as nonpsychoactive. It is also found in black pepper and cloves.

Does Beta-Caryophyllene Help With Pain or Inflammation?

In mice, oral beta-caryophyllene reduced inflammation and some types of pain through CB2. We found no controlled human trials confirming those effects as part of cannabis.

Which Foods Contain Beta-Caryophyllene?

It is common in spice and food plants, notably black pepper and cloves, and it is also present in hops.

Sources

Editorial note: This article summarizes published research for general education. Most terpene research comes from cells and animals; where a human study exists, we say so and give its size. It is not medical advice, makes no treatment claims, and contains no affiliate links.

Subscribe to CannaWize

Get notified of our latest cannabis news, research explainers, and practical guides for adults.

By subscribing, you agree to receive the CannaWize Brief. Unsubscribe anytime. Privacy Policy.

Subscribe to CannaWize

Cannabis news, research explainers, and practical guides, sent when they matter.

By subscribing, you agree to receive the CannaWize Brief. Unsubscribe anytime. Privacy Policy.